ANXA2 and cancer: In addition, Ginsenoside compound K exhibits remarkable anti-tumor activity in several types of cancer cells and animal models by inhibiting the nuclear colocalization of and interaction between ANXA2 and the p50 subunit of NF-кB to prevent the activation of NF-кB and the expression of downstream genes [62].